Canada markets closed

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
88.69+2.33 (+2.70%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close86.36
Open89.60
Bid89.02 x 1400
Ask89.45 x 900
Day's Range87.06 - 89.99
52 Week Range16.12 - 105.00
Volume2,079,717
Avg. Volume2,733,151
Market Cap21.124B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateAug. 11, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est81.64
  • Motley Fool

    What's the Timeline for FDA Emergency Use Authorization of Coronavirus Vaccines?

    Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) should know very soon if their coronavirus vaccine candidate BNT172b2 works. The two companies expect to be able to file for Emergency Use Authorization (EUA) with the Food and Drug Administration by the third week of November. How long will it take the FDA to make a decision?

  • Yahoo Finance Video

    COVID-19 'Pool testing' in schools would give insight on how well masks in schools are doing: Dr. Dara Kass

    Yahoo Finance’s Alexis Christoforous and Brian Sozzi discuss the latest news on the COVID-19 vaccine front with Yahoo Medical Contributor, Dr. Dara Kass.

  • 2 Popular But Overvalued Biotech Stocks to Avoid
    Motley Fool

    2 Popular But Overvalued Biotech Stocks to Avoid

    Moderna (NASDAQ: MRNA) and BioNTech (NASDAQ: BNTX) have been hot stocks this year. At the same time, as rumors swirl regarding the conclusions of each company's phase 3 clinical trials, investors everywhere are hunting for the best competitors in the rapidly expanding coronavirus market. Given that both Moderna and BioNTech have exhibited lightning-fast vaccine development, it's anyone's guess as to which has a better chance of winning the coronavirus vaccine race.